MediaKit

Official XXIst International Pigment Cell Conference website - 21-24 Sept 2011, Bordeaux - France | updated: August 13 2011

Press

The IPCC is a triennal meeting which brings together scientists and physicians active in the pigment cell community from all over the world. Pigment cells produce melanins which colour our skin but are also useful for the proper function of our eyes, ears, brain and other internal organs. Melanins are also of interest because of their unique physicochemical properties and are now used in industrial applications. Scientists have unveiled many mysteries of the pigment cell system over the last decades, but many aspects remain unclear and exchanges between the various disciplines are needed to stimulate new research ideas, and cross fertilize the field via new collaborations. To cite a few branches involved, dermatology, ophthalmology, neurology, cell and developmental biology, biochemistry, molecular biology are all strongly represented at IPCC meetings.

The International Federation of Pigment Cell Societies (IFPCS) is the official sponsor of the conference. It federates the American, Japanese, Asian and European regional pigment cell societies. The IFPCS has chosen Bordeaux for the 2011 IPCC, after Washington (USA) and Sapporo (Japan).

The IPCC will cover important medical aspects of pigmentation, with a special focus on dermatological disorders because of the host department orientation. Prof Alain Taîeb heads the department of Dermatology at Bordeaux University hospitals and has a special interest for rare pigment cell and photoprotection disorders but also more common ones like vitiligo. However, many other aspects important in the field, such as stem cells, Parkinson's disease, animal models, new development in systems biology and new technologies, medical and surgical approaches in disfiguring disorders of pigmentation will be covered.

A joint day with the Society for Melanoma Research (SMR) will highlight the latest advances in this fast moving field. Melanoma is one of the most difficult to treat cancers at the metastatic stage, but new treatments based on the definition of specific molecular targets are hopefully emerging.

Posters

Please download our iPCC2011 big size Poster here.

How to link

Any help? Please ask webmaster@ipcc2011.org !

Links

Advertisement from our sponsor: